SDSandryne David

Sandryne David

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandryne David has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Macroscopic inelastic scattering imaging using a hyperspectral line-scanning system identifies invasive breast cancer in lumpectomy and mastectomy specimens

    by Sandryne David, Hugo Tavera, Tran Trang, Frédérick Dallaire, François Daoust, Francine Tremblay, Lara Richer, Sarkis Meterissian, Frédéric Leblond

    SignificanceOf patients with early-stage breast cancer, 60% to 75% undergo breast-conserving surgery. Of those, 20% or more need a second surgery because of an incomplete tumor resection only discovered days after surgery. An intraoperative imaging technology allowing cancer detection on the margins of breast specimens could reduce re-excision procedure rates and improve patient survival.AimWe aimed to develop an experimental protocol using hyperspectral line-scanning Raman spectroscopy to image fresh breast specimens from cancer patients. Our objective was to determine whether macroscopic specimen images could be produced to distinguish invasive breast cancer from normal tissue structures.ApproachA hyperspectral inelastic scattering imaging instrument was used to interrogate eight specimens from six patients undergoing breast cancer surgery. Machine learning models trained with a different system to distinguish cancer from normal breast structures were used to produce tissue maps with a field-of-view of 1 cm2 classifying each pixel as either cancer, adipose, or other normal tissues. The predictive model results were compared with spatially correlated histology maps of the specimens.ResultsA total of eight specimens from six patients were imaged. Four of the hyperspectral images were associated with specimens containing cancer cells that were correctly identified by the new ex vivo pathology technique. The images associated with the remaining four specimens had no histologically detectable cancer cells, and this was also correctly predicted by the instrument.ConclusionsWe showed the potential of hyperspectral Raman imaging as an intraoperative breast cancer margin assessment technique that could help surgeons improve cosmesis and reduce the number of repeat procedures in breast cancer surgery.


  • Towards Real-Time Confirmation of Breast Cancer in the OR Using CNN-Based Raman Spectroscopy Classification

    by David Grajales, William Le, Frédérick Dallaire, Guillaume Sheehy, Sandryne David, Trang Tran, Frédéric Leblond, Cynthia Ménard, Samuel Kadoury


  • Open Access

    In situ Raman spectroscopy and machine learning unveil biomolecular alterations in invasive breast cancer

    by Sandryne David, Trang Tran, Frédérick Dallaire, Guillaume Sheehy, Feryel Azzi, Dominique Trudel, Francine Tremblay, Atilla Omeroglu, Frédéric Leblond, Sarkis Meterissian

    Breast cancer is the most diagnosed cancer worldwide. It accounted for 1 in 8 cancer diagnoses and 685,000 deaths in 2020.1,2 It is the leading cause of cancer mortality in women and may affect men in rare cases.1,3 Early diagnosis and effective treatment are critical factors for survival.4 Ductal carcinoma is the most common type of breast cancer, and it originates in epithelial cells lining the interior of the ducts that carry milk from glands to the nipple. Lobular carcinoma, the second most common breast cancer type, originates from cells within the lobules, which are groups of glands connected to the duct. These carcinomas may be in situ or invasive.5 In situ cancers have not grown into surrounding tissues, whereas invasive cancer cells have initiated molecular processes allowing them to spread beyond the tissue of origin.5 There are two major types of in situ breast cancers: ductal carcinoma in situ and lobular carcinoma in situ.6